Many companies that sell artificial intelligence (AI) services have seen their share price skyrocket over the past couple of ...

Stocks struggled to find direction after a Federal Court struck down the tariffs that the Trump administration proposed on “Liberation Day.” The ruling was reversed on appeal, but it adds another ...

Regeneron Pharmaceuticals (NasdaqGS:REGN) announced favorable Phase 3 trial results for itepekimab and entered a significant licensing agreement with Telesis Bio, enhancing its R&D capabilities.

Have you ever read a headline that made you want to throw your phone across the room? Not out of anger, but frustration for your own bad investing decisions? You know the headlines I mean. “NVIDIA up ...